Exane Derivatives’s Cloudera CLDR Stock Holding History
Bought
Maintained
Sold
Exane Derivatives's CLDR Position: Q4 2021 in Review
Exane Derivatives sold out of Cloudera (CLDR) in Q4 2021, closing a stake of 62 shares — an estimated $990 sold.
Exane Derivatives first reported a position in CLDR in Q2 2020 and held it in 6 quarters. The position peaked at $174K in Q2 2020. 0 funds tracked by Wall St. Rank hold CLDR as of Q4 2021.
- Exane Derivatives reported no remaining Cloudera position as of Q4 2021 after selling out during the quarter.
- Exane Derivatives sold 62 Cloudera shares in Q4 2021, an estimated $990.
- Exane Derivatives first reported a position in Cloudera in Q2 2020 and held it in 6 quarters.
- Exane Derivatives's Cloudera position peaked at $174K in Q2 2020.
- 0 funds tracked by Wall St. Rank held Cloudera as of Q4 2021.
Based on Exane Derivatives's 13F filing for Q4 2021, filed 28 Jan 2022.